Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 17, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2021. Go to the latest filing (Q3 2026)

33.6B USDQ1 2021
Total value of stock positions
33.6B USD
Positions
94
Share of the ten largest
37.1%

The ten largest positions Q1 2021

  1. Microsoft 6.0%▼ −28.1%
  2. Bridgebio Pharma Inc 4.9%unchanged
  3. Fidelity National Information Services 4.0%▼ −18.9%
  4. T-Mobile US 3.8%▲ +18.1%
  5. Bank of America 3.6%new
  6. Adaptive Biotechnologies Cor 3.6%unchanged
  7. UnitedHealth Group 3.4%▲ +10.3%
  8. Alphabet Inc. (Class A) 2.8%▼ −26.7%
  9. Visa Inc. 2.5%▼ −1.2%
  10. Palo Alto Networks 2.4%▲ +32.9%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2021

Positions Q1 2021 per 13F filing, 50 of 94
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 1.7% 181,067 560.2M USD −9.7% reduced Q2 2015 24 quarters
MSFT Microsoft 6.0% 8,516,030 2.0B USD −28.1% reduced Q2 2016 20 quarters
V Visa Inc. 2.5% 4,038,509 855.1M USD −1.2% reduced Q3 2016 19 quarters
Catalent Inc 0.2% 754,380 79.4M USD −37.3% reduced Q1 2018 13 quarters
CNC Centene Corporation 2.1% 10,977,051 701.5M USD −16.1% reduced Q2 2018 12 quarters
BSX Boston Scientific 2.1% 17,896,102 691.7M USD −40.3% reduced Q3 2018 11 quarters
AON Aon plc 1.5% 2,154,489 495.8M USD −16.2% reduced Q3 2018 11 quarters
Blueprint Medicines Corp < 0.1% 213,050 20.7M USD −21.9% reduced Q3 2018 11 quarters
MELI MercadoLibre 0.7% 161,293 237.4M USD −60.8% reduced Q1 2019 9 quarters
Bridgebio Pharma Inc 4.9% 26,620,991 1.6B USD unchanged Q2 2019 8 quarters
Adaptive Biotechnologies Cor 3.6% 29,993,708 1.2B USD unchanged Q2 2019 8 quarters
Avantor Inc 1.3% 15,507,888 448.6M USD +16.1% increased Q2 2019 8 quarters
AIZ Assurant 1.2% 2,776,100 393.6M USD +0.6% increased Q2 2019 8 quarters
FTV Fortive 2.4% 11,190,141 790.5M USD +40.5% increased Q3 2019 7 quarters
Guardant Health Inc 1.3% 2,918,223 445.5M USD −17.4% reduced Q3 2019 7 quarters
Molina Healthcare Inc 1.0% 1,433,753 335.2M USD +40.2% increased Q3 2019 7 quarters
FIS Fidelity National Information Services 4.0% 9,598,474 1.3B USD −18.9% reduced Q4 2019 6 quarters
SE Sea Limited (ADR) 0.8% 1,263,193 282.0M USD −33.7% reduced Q4 2019 6 quarters
CI Cigna 0.4% 579,029 140.0M USD −70.4% reduced Q4 2019 6 quarters
TMUS T-Mobile US 3.8% 10,285,244 1.3B USD +18.1% increased Q1 2020 5 quarters
CB Chubb Limited 2.0% 4,181,823 660.6M USD +54.5% increased Q1 2020 5 quarters
IR Ingersoll Rand 0.8% 5,370,312 264.3M USD −12.6% reduced Q1 2020 5 quarters
Horizon Therapeutics Pub L 0.6% 2,115,657 194.7M USD −42.2% reduced Q1 2020 5 quarters
JPM JPMorgan Chase 0.4% 874,417 133.1M USD −89.7% reduced Q1 2020 5 quarters
Api Group Corp 2.1% 33,333,333 689.3M USD unchanged Q2 2020 4 quarters
MCO Moody's Corporation 1.5% 1,716,016 512.4M USD +4.3% increased Q2 2020 4 quarters
Nuance Communications Inc 1.4% 11,088,603 483.9M USD −32.3% reduced Q2 2020 4 quarters
TMO Thermo Fisher Scientific 1.2% 861,887 393.3M USD +1,007.6% increased Q2 2020 4 quarters
ALGN Align Technology 0.9% 544,681 295.0M USD +1.8% increased Q2 2020 4 quarters
PH Parker Hannifin 0.8% 818,184 258.1M USD −51.4% reduced Q2 2020 4 quarters
Zentalis Pharmaceuticals Inc 0.3% 2,399,284 104.1M USD −20.3% reduced Q2 2020 4 quarters
Pvh Corporation 0.3% 933,212 98.6M USD +12.7% increased Q2 2020 4 quarters
Royalty Pharma PLC 0.3% 2,061,753 89.9M USD −9.8% reduced Q2 2020 4 quarters
GOOGL Alphabet Inc. (Class A) 2.8% 454,358 937.1M USD −26.7% reduced Q3 2020 3 quarters
Fleetcor Technologies Inc 2.1% 2,632,323 707.1M USD +16.0% increased Q3 2020 3 quarters
ZBH Zimmer Biomet 1.8% 3,820,971 611.7M USD −1.2% reduced Q3 2020 3 quarters
OTIS Otis Worldwide 1.4% 6,834,220 467.8M USD +26.6% increased Q3 2020 3 quarters
BMY Bristol Myers Squibb 1.0% 5,195,473 328.0M USD +107.3% increased Q3 2020 3 quarters
Laboratory Corp Amer HLDGS 0.8% 1,081,219 275.7M USD +1,044.1% increased Q3 2020 3 quarters
PODD Insulet Corporation 0.8% 1,035,964 270.3M USD +114.3% increased Q3 2020 3 quarters
SNOW Snowflake 0.4% 627,157 143.8M USD unchanged Q3 2020 3 quarters
Unity Software Inc 0.4% 1,409,981 141.4M USD unchanged Q3 2020 3 quarters
VRSN Verisign 0.4% 690,033 137.2M USD −53.0% reduced Q3 2020 3 quarters
Inhibrx Inc 0.3% 5,305,866 106.5M USD unchanged Q3 2020 3 quarters
Karuna Therapeutics Inc 0.2% 601,144 72.3M USD +77.7% increased Q3 2020 3 quarters
Pmv Pharmaceuticals Inc 0.2% 2,086,284 68.6M USD −11.8% reduced Q3 2020 3 quarters
Athira Pharma Inc 0.1% 2,120,653 39.0M USD unchanged Q3 2020 3 quarters
Pacific Biosciences Calif In < 0.1% 293,335 9.8M USD −81.2% reduced Q3 2020 3 quarters
UNH UnitedHealth Group 3.4% 3,080,874 1.1B USD +10.3% increased Q4 2020 2 quarters
PANW Palo Alto Networks 2.4% 2,508,314 807.8M USD +32.9% increased Q4 2020 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 94 positions.

Breakdown by sector

  • Financials 19.6%
  • Health Care 14.9%
  • Technology 10.6%
  • Communication Services 9.9%
  • Industrials 9.2%
  • Consumer Discretionary 3.6%
  • not in our coverage 32.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close